Excelsior News and Activities

Acquisition, funding and merger involving Excelsior.

• Excelsior has just announced a $95 Million fundraising (posted on December 5 2025).

View the org chart displaying its 14 main executives

Most searched biographies at Excelsior

• Michael Foley, Chief Executive Officer
• Edward Kliphuis, Director
• Jim Flynn, Director

Create your alert
to follow the executive moves at Excelsior.

Excelsior has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 9 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Excelsior

Social media about Excelsior

• Excelsior on Wikipedia, Google News & Yahoo Finance
• Excelsior on LinkedIn, X (Twitter) & YouTube